DEA Investigations
DEA inspections, controlled substance compliance, and Drug Supply Chain Security Act enforcement.
DEA Registration Denials and the Public Interest Factors
DEA weighs five statutory public interest factors before denying or renewing a physician's registration, and prior board disciplin…
DEA Recordkeeping: The Audit-Ready Controlled Substance File
What pharmacies must document under DEA recordkeeping rules, from biennial inventories to theft and loss reports, before an inspec…
Responding to a DEA Order to Show Cause
A DEA order to show cause starts a 30-day deadline to request a hearing. Here are the grounds for revocation and the settlement pa…
DEA Inspections: A Pharmacy's Rights and Obligations
DEA investigators at the pharmacy door: the difference between a warrant and a consent request, and the lawful scope limits on eit…
DEA Immediate Suspension Orders: The Imminent Danger Standard
An Immediate Suspension Order halts controlled substance dispensing the moment it is served. Here is the imminent danger standard…
New Executive Order Signals Faster Psychedelic Drug Approvals--and Closer DEA Scrutiny
On Saturday, April 18, President Trump signed an executive order designed to accelerate federal drug approvals for psychedelic dru…
DOJ Targets Ketamine Clinics: Federal Charges Lead to Prison and Probation for Two Providers
The explosion in demand for ketamine-assisted psychotherapy (“KAP”) has garnered significant media attention over the past few yea…
Health Law Alliance Successfully Sues the DEA and its Administrator, Terrance Cole, in Federal Court to Lift Immediate Suspension Order
Health Law Alliance is proud to announce a major victory in federal court, where it successfully secured the immediate lifting of…
Resolving Prescription “Red Flags” Is No Longer Optional: Federal Scrutiny Tightens on Controlled-Substance Dispensing
Pharmacists must resolve “red flags” under the Controlled Substances Act’s corresponding-responsibility requirements before dispen…